Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Person

Linda Marban

Tracked across 3 events · 578 articles · First seen Jun 26, 2026 · Last active Sep 21, 2026

Sentiment
-37
Attention
6
Events
3
Relationships
8
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
6 -80
Regulatory
Impact: CEO who made positive statements about Deramiocel; now named in securities fraud lawsuits.
Jul 27, 2026 · 305 articles
6 0
Regulatory
Impact: Linda Marban, CEO of Paragon Therapeutics, expressed confidence in the evidence supporting Deramiocel and emphasized the company's commitment to bringing the therapy to patients.
Jun 26, 2026 · 6 articles
4 -30
Regulatory
Paragon Therapeutics, Inc. (NASDAQ: CAPR) and certain of its officers are defendants in a securities fraud class action pending in the United States — United States District Court for the Southern District of California, captioned…
Impact: Capricor's CEO, whose positive statements about HOPE-3 and Deramiocel are cited in the complaint as materially misleading.
Aug 10, 2026 · 267 articles
80 Linda Marban named as defendantCapricor Deramiocel...
80 Linda Marban named as defendantCapricor Deramiocel...
ERGEN INTELLIGENCE
Track Linda Marban live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.